Keyphrases
Ciprofloxacin
96%
Register Study
54%
National Cohort Study
51%
Induced Lactation
48%
Major Congenital Malformations
48%
Glycemic Control
48%
Adverse Pregnancy Outcomes
48%
Early Risk
48%
Early Pregnancy
48%
Aged 80 Years and over
48%
Spontaneous Preterm Birth (sPTB)
48%
Glucose-lowering Drugs
48%
KRAS G12C
48%
Major Malformations
48%
Tramadol
48%
Hemoglobin A1c (HbA1c)
48%
Type 2 Diabetic Patients
48%
Treatment Patterns
48%
Overall Survival
48%
Term Placenta
48%
Cancer Characteristics
48%
Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC)
48%
Therapeutic Concentrations
48%
EudraVigilance
48%
Miscarriage
42%
Maternal Exposure
39%
Type 2 Diabetes Mellitus (T2DM)
32%
Domperidone
32%
Hazard Ratio
26%
Relative Infant Dose
24%
Denmark
18%
Time to Next Treatment
18%
PD-L1 Expression
18%
Physical Stimulation
15%
Older Patients
15%
Risk Ratio
15%
Medication Use
15%
Diagnostic Criteria
15%
Hormonal Changes
15%
High Dose
15%
Estrogen-progestin
15%
Parental Expectations
15%
Potential Risk
15%
Adverse Drug Reaction
15%
Off-label Use
15%
Lactation
15%
Metoclopramide
15%
Prescribing Drugs
15%
Placenta
13%
Fetal Exposure
13%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
100%
Congenital Malformation
96%
Spontaneous Abortion
96%
Ciprofloxacin
96%
Overall Survival
48%
Tramadol
48%
Domperidone
48%
Non Small Cell Lung Cancer
48%
Non Insulin Dependent Diabetes Mellitus
48%
Prescription Drug
48%
Maternal Exposure
39%
Hemoglobin A1c
36%
Prevalence
31%
Prescribing Drug
24%
Progestin
24%
Metoclopramide
24%
Adverse Drug Reaction
24%
Off-Label Use
24%
Infection
12%
Immunotherapy
8%
Epidermal Growth Factor Receptor
8%
Neoplasm
8%
Hemorrhoid
8%
Hypoglycemia
6%
Stillbirth
6%
Medicine and Dentistry
Cohort Analysis
48%
Congenital Malformation
48%
Spontaneous Abortion
48%
Non Small Cell Lung Cancer
48%
Ciprofloxacin
48%
Overall Survival
48%
Lactation
48%
Programmed Death-Ligand 1
32%
Childbirth
24%
Domperidone
24%
Hazard Ratio
18%
Prevalence
15%
Physical Stimulation
12%
Maternal Exposure
12%
Off-Label Use
12%
Metoclopramide
12%
Gestagen
12%
Drug Megadose
12%
Prescribing Drug
12%
Adverse Drug Reaction
12%
Immunotherapy
8%
Neoplasm
8%
Epidermal Growth Factor Receptor
8%
Smoking
8%
Patient Characteristics
8%
Infant Nutrition
8%
Proportional Hazards Model
6%
First Trimester Pregnancy
6%
Medical Intervention
6%
Stillbirth
6%
